Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Private-equity firms’ involvement in health care increases prices, reduces quality, and encourages exploitation of patients due to pressure from investors.

Fuse Brown and Hall ‘23

Erin C. and Mark A., Director of Center for Law, Health, and Inequality at Georgia State University and Director of Health Law and Policy Program at Wake Forest University, “Private Equity and The Corporatization of Health Care”, Social Science Research Network, March 1 2023. @SL

Many public policy analysts are worried that PE investment in health care contributes to the commercialization of health care, fuels consolidation and rising costs, and is bad for patient access, outcomes, and professional practice. Private equity is exceptionally adept at identifying and exploiting market failures that can be turned into profit for investors. PE investors may not be the only ones who can capitalize on these market failures. However, they are more likely to find these opportunities to profit from payment loopholes or market dysfunctions and move aggressively into that space. Hence, as we have argued elsewhere, PE functions as a divining rod for finding market failures—where PE has penetrated, it is a good bet that there is a profit opportunity ripe for exploitation. There are three main risks that PE investment appears to pose to patients, medical professionals, and the health care market overall. First, PE investment spurs health care consolidation, which increases prices and potentially reduces quality and access.60 Second, the pressure from PE Investors to increase revenue can lead to exploitation of billing loopholes, overutilization, up-coding, aggressive risk-coding, harming patients through unnecessary care, excessive bills, and increasing overall health spending.61 Third, physicians acquired by PE companies may be subject to onerous employment terms and lose autonomy over clinical decisions and their practice of medicine.62 Although the data are still being developed, early evidence supports several of these concerns. In the hospital context, PE acquisition has been associated with increased net income, charges (the asking price), markups over costs, and the proportion of privately insured patients. 63 Among nursing homes, evidence of the impact of PE on patient outcomes is particularly troubling. Researchers found that Medicare patients in private equity-owned nursing facilities suffered a 10% increase in 90-day mortality between 2004-2016 (i.e., pre-pandemic), and that this increased risk of death could have been due to reduced staffing levels. 64 Other quality measures also declined following the acquisition, even as per-patient spending increased.65 The impact of PE investment in physician practices shows similar risks of higher prices, increased spending, and reduced staffing levels. One study, for instance, documented that when hospitals contracted with either of the two largest physician staffing companies for emergency services, both of which have PE investors, this led to substantially higher prices, increased testing and hospital admissions, and more aggressive billing practices.66 Another study found that PE-acquired physician practices specializing in dermatology, gastroenterology, and ophthalmology increased health spending and utilization, compared with controls. 67 A separate study of dermatology practices found that PE targeted larger practices for acquisition and that PE acquisition led to higher prices and patient volumes compared to controls, 68 and similar results were found for PE investment in anesthesia practices. 69 In terms of staffing impacts, PE ownership of surgical dermatology practices is associated with higher ratios of nonphysician providers to physicians and lower staffing levels overall, particularly for non-revenue generating staff. 70 Compared to non-PE-acquired practices, PE-owned dermatology, ophalmology, and gastroenterology practices showed higher physician turnover and a the addition of more mid-level staff, suggesting that physician satisfaction may be lower in PE-owned practices, and that additional PE-driven practice growth may be absorbed at a lower cost by a greater reliance on mid-level practitioners.71 To be sure, not all studies have shown clear adverse effects.72 Moreover, there are some potential benefits to consider, such as: access to capital, efficiencies, allowing physicians graduating with medical debt to join practices, and offloading practice management burden from physicians.73 Yet, regulators and policymakers must attend to the risks to patient care, health care spending, and physicians’ clinical autonomy posed by rampant PE-investment in health care.

Sign in to recut, update, or save this card.